glucagon like peptide 1 glp 1 drugs GLP-1 Receptor Agonist Services for Type 2 Diabetes and Obesity Drug Development Glucagon-like peptide 1 (GLP-1) -

Unlike quick fixes, this formula harnesses clinically studied ingredients that help your body burn fat for energy, balance blood sugar levels, and minimize fat accumulation while preserving lean mass

Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases

(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists

Learn about their benefits and side effects.

You may have been reading a lot about newly launched obesity drugs and I covered some of this in my podcast last year with Stephan Guyenet in anticipation